Covered recipient · General Payments record
THOMAS CHRISTOPHER SANCHEZ
Allopathic & Osteopathic Physicians Anesthesiology
General Payments · PY2018–2024
$5,404.70
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $296.45 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $50.64 | 2 |
| ABBVIE INC. | $42.23 | 2 |
| ARGENX US, INC. | $37.42 | 2 |
| EMD Serono, Inc. | $28.65 | 1 |
| Biogen, Inc. | $27.56 | 2 |
| BANNER LIFE SCIENCES, LLC | $20.60 | 1 |
| Neurelis, Inc. | $19.85 | 1 |
| PFIZER INC. | $19.62 | 1 |
| Lundbeck LLC | $18.70 | 1 |
| GENZYME CORPORATION | $16.03 | 1 |
| Avadel CNS Pharmaceuticals, LLC | $15.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.87 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106012841 | CMS |
| ABBVIE INC. | $17.36 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106012843 | CMS |
| ARGENX US, INC. | $13.45 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142112277 | CMS |
| ARGENX US, INC. | $23.97 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142123629 | CMS |
| Avadel CNS Pharmaceuticals, LLC | $15.15 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123387606 | CMS |
| BANNER LIFE SCIENCES, LLC | $20.60 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147029763 | CMS |
| Biogen, Inc. | $13.20 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104867382 | CMS |
| Biogen, Inc. | $14.36 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104875334 | CMS |
| Eisai Inc. | $24.86 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785573 | CMS |
| Eisai Inc. | $25.78 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110785571 | CMS |
| EMD Serono, Inc. | $28.65 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120266083 | CMS |
| GENZYME CORPORATION | $16.03 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139664832 | CMS |
| Lundbeck LLC | $18.70 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145965104 | CMS |
| Neurelis, Inc. | $19.85 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145652964 | CMS |
| PFIZER INC. | $19.62 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131242631 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.